T2	Participants 283 332	group of nonimmune tourists to sub-Saharan Africa
T3	Participants 342 477	In a randomized, double-blind, four-arm study with placebo run-in phase conducted at travel clinics in Switzerland, Germany, and Israel
T1	Participants 35 59	malaria chemoprophylaxis
#1	AnnotatorNotes T2	both gender
